Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Induction of DNA synthesis in isolated nuclei by cytoplasmic factors: inhibition by protease inhibitors.
Wong RL
,
Gutowski JK
,
Katz M
,
Goldfarb RH
,
Cohen S
.
???displayArticle.abstract???
Cytoplasmic extracts from spontaneously proliferating and mitogen-activated lymphoid cells contain a protein factor called ADR (activator of DNA replication) that induces DNA synthesis in isolated quiescent nuclei. ADR-containing preparations have proteolytic activity, as indicated by their ability to degrade fibrin in a plasminogen-independent and plasminogen-dependent manner. In addition, aprotinin, a nonspecific protease inhibitor, abrogates ADR-induced DNA synthesis in a dose-dependent fashion. Preincubation studies demonstrated that the effect of aprotinin is not due to its suppressive effects on the nuclei themselves. Other protease inhibitors such as leupeptin, p-aminobenzamidine, and N-alpha-tosyllysine chloromethyl ketone are also inhibitory, but soybean trypsin inhibitor is without effect. ADR activity can be removed from active extracts by adsorption with aprotinin-conjugated agarose beads and can be recovered by elution with an acetate buffer (pH 5). These findings are consistent with the interpretation that the initiation of DNA synthesis in resting nuclei may be protease dependent and, further, that the cytoplasmic stimulatory factor we have called ADR may be a protease itself.
Baugh,
Human leukocyte granule elastase: rapid isolation and characterization.
1976, Pubmed
Baugh,
Human leukocyte granule elastase: rapid isolation and characterization.
1976,
Pubmed
Benbow,
Cytoplasmic control of nuclear DNA synthesis during early development of Xenopus laevis: a cell-free assay.
1975,
Pubmed
,
Xenbase
Benz,
Viral and cellular DNA synthesis in nuclei from human lymphocytes transformed by Epstein-Barr virus.
1975,
Pubmed
Brown,
Protease activation of G1 nuclei isolated from Chinese hamster fibroblasts.
1977,
Pubmed
Brown,
Enhancement of DNA synthesis in a mammalian cell-free system by trypsin treatment.
1974,
Pubmed
Carney,
Conditions which affect initiation of animal cell division by trypsin and thrombin.
1978,
Pubmed
Chen,
Mitogenic activity of blood components. I. Thrombin and prothrombin.
1975,
Pubmed
Chou,
Non-selective inhibition of transformed cell growth by a protease inhibitor.
1974,
Pubmed
Das,
Mitogenic hormone-induced intracellular message: assay and partial characterization of an activator of DNA replication induced by epidermal growth factor.
1980,
Pubmed
Floros,
Stimulated DNA synthesis in frog nuclei by cytoplasmic extracts of temperature-sensitive mammalian cells.
1978,
Pubmed
,
Xenbase
Goldfarb,
Purification of plasminogen activator from Rous sarcoma virus transformed chick embryo fibroblasts treated with the tumor promoter phorbol 12-myristate 13-acetate.
1980,
Pubmed
Goldfarb,
Production of plasminogen activator by human natural killer cells. Large granular lymphocytes.
1984,
Pubmed
Grayzel,
Protease activity of normal and PHA stimulated human lymphocytes.
1975,
Pubmed
Gutowski,
Induction of DNA synthesis in isolated nuclei by cytoplasmic factors from spontaneously proliferating and mitogen-activated lymphoid cells.
1983,
Pubmed
,
Xenbase
Gutowski,
The role of cytoplasmic intermediates in IL 2-induced T cell growth.
1984,
Pubmed
Hirschhorn,
The effect of epsilon amino caproic acid and other inhibitors of proteolysis upon the response of human peripheral blood lymphocytes to phytohemagglutinin.
1971,
Pubmed
Jazwinski,
Initiation of replication in chromosomal DNA induced by extracts from proliferating cells.
1976,
Pubmed
Jazwinski,
Acitivity of yeast extracts in cell-free stimulation of DNA replication.
1976,
Pubmed
,
Xenbase
Johnson,
Phosphorylation of lymphocyte nuclear acidic proteins: regulation by cyclic nucleotides.
1975,
Pubmed
Kishimoto,
Involvement of anti-Ig-activated serine protease in the generation of cytoplasmic factor(s) that are responsible for the transmission of Ig-receptor-mediated signals.
1979,
Pubmed
Ku,
The inhibition of the mitogenic stimulation of B lymphocytes by a serine protease inhibitor: commitment to proliferation correlates with an enhanced expression of a cell-associated arginine-specific serine enzyme.
1983,
Pubmed
Kupfer,
Affinity labeling of the catalytic subunit of cyclic AMP-dependent protein kinase by N alpha-tosyl-L-lysine chloromethyl ketone.
1979,
Pubmed
MOSESSON,
The preparation of human fibrinogen free of plasminogen.
1962,
Pubmed
Nishizawa,
Induction and properties of cytoplasmic factor(s) which enhance nuclear nonhistone protein phosphorylation in lymphocytes stimulated by anti-Ig.
1977,
Pubmed
Pogo,
Early events in lymphocyte transformation by phytohaemagglutinin. 2. Synthesis and phosphorylation of nuclear proteins.
1974,
Pubmed
Richert,
Inhibition of the transformation-specific kinase in ASV-transformed cells by N-alpha-tosyl-L-lysyl chloromethyl ketone.
1979,
Pubmed
Saito,
Involvement of proteolytic acivity in early events in lymphocyte transformation by phytohemagglutinin.
1973,
Pubmed
Schnebli,
Selective inhibition of growth of transformed cells by protease inhibitors.
1972,
Pubmed
Zyznar,
A rationale for the application of trasylol as a protease inhibitor in radioimmunoassay.
1981,
Pubmed
